FCRL1_MOUSE
ID FCRL1_MOUSE Reviewed; 343 AA.
AC Q8R4Y0; Q68SP0; Q7TMH2; Q80WN3; Q8BYS4;
DT 29-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT 01-JUN-2002, sequence version 1.
DT 25-MAY-2022, entry version 131.
DE RecName: Full=Fc receptor-like protein 1;
DE Short=FcR-like protein 1;
DE Short=FcRL1;
DE AltName: Full=BXMAS1-like protein 1;
DE Short=mBXMH1;
DE AltName: Full=Fc receptor homolog 1;
DE Short=FcRH1;
DE Short=moFcRH1;
DE AltName: Full=IFGP family protein 1;
DE Short=mIFGP1;
DE AltName: CD_antigen=CD307a;
DE Flags: Precursor;
GN Name=Fcrl1; Synonyms=Fcrh1, Ifgp1;
OS Mus musculus (Mouse).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Mus; Mus.
OX NCBI_TaxID=10090;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC STRAIN=C57BL/6J; TISSUE=Mammary gland;
RX PubMed=12037601; DOI=10.1007/s00251-002-0436-x;
RA Guselnikov S.V., Ershova S.A., Mechetina L.V., Najakshin A.M.,
RA Volkova O.Y., Alabyev B.Y., Taranin A.V.;
RT "A family of highly diverse human and mouse genes structurally links
RT leukocyte FcR, gp42 and PECAM-1.";
RL Immunogenetics 54:87-95(2002).
RN [2]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY.
RC STRAIN=BALB/cJ; TISSUE=Spleen;
RX PubMed=15302849; DOI=10.1093/intimm/dxh137;
RA Davis R.S., Stephan R.P., Chen C.-C., Dennis G. Jr., Cooper M.D.;
RT "Differential B cell expression of mouse Fc receptor homologs.";
RL Int. Immunol. 16:1343-1353(2004).
RN [3]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 4).
RC STRAIN=C57BL/6J;
RA Nakayama Y., Maher S.E., Weissman S.M., Bothwell A.L.M.;
RT "Molecular cloning of mouse BXMAS1 homologs; homologous to IgFc receptor.";
RL Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases.
RN [4]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC STRAIN=C57BL/6J; TISSUE=Hypothalamus, and Spleen;
RX PubMed=16141072; DOI=10.1126/science.1112014;
RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT "The transcriptional landscape of the mammalian genome.";
RL Science 309:1559-1563(2005).
RN [5]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC STRAIN=FVB/N; TISSUE=Mammary tumor;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
CC -!- FUNCTION: May function as an activating coreceptor in B-cells. May
CC function in B-cells activation and differentiation (By similarity).
CC {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I
CC membrane protein {ECO:0000250}.
CC -!- ALTERNATIVE PRODUCTS:
CC Event=Alternative splicing; Named isoforms=4;
CC Name=1; Synonyms=a, long;
CC IsoId=Q8R4Y0-1; Sequence=Displayed;
CC Name=2; Synonyms=short;
CC IsoId=Q8R4Y0-2; Sequence=VSP_033296;
CC Name=3;
CC IsoId=Q8R4Y0-3; Sequence=VSP_033299;
CC Name=4; Synonyms=b;
CC IsoId=Q8R4Y0-4; Sequence=VSP_033297, VSP_033298;
CC -!- TISSUE SPECIFICITY: Widely expressed. Expressed in B-cells at the
CC various stages of differentiation. {ECO:0000269|PubMed:12037601,
CC ECO:0000269|PubMed:15302849}.
CC -!- PTM: Phosphorylated on tyrosines upon activation. {ECO:0000250}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF329485; AAM11542.1; -; mRNA.
DR EMBL; AY506554; AAS91574.1; -; mRNA.
DR EMBL; AY506555; AAS91575.1; -; mRNA.
DR EMBL; AY158088; AAO20871.1; -; mRNA.
DR EMBL; AY158089; AAO20872.1; -; mRNA.
DR EMBL; AK038494; BAC30017.1; -; mRNA.
DR EMBL; AK156985; BAE33923.1; -; mRNA.
DR EMBL; BC055830; AAH55830.1; -; mRNA.
DR CCDS; CCDS17452.1; -. [Q8R4Y0-1]
DR CCDS; CCDS50942.1; -. [Q8R4Y0-2]
DR CCDS; CCDS79937.1; -. [Q8R4Y0-3]
DR RefSeq; NP_001129708.1; NM_001136236.1.
DR RefSeq; NP_001297474.1; NM_001310545.1.
DR RefSeq; NP_694730.2; NM_153090.2.
DR RefSeq; NP_835459.1; NM_178165.4.
DR AlphaFoldDB; Q8R4Y0; -.
DR SMR; Q8R4Y0; -.
DR STRING; 10090.ENSMUSP00000130936; -.
DR GlyGen; Q8R4Y0; 2 sites.
DR iPTMnet; Q8R4Y0; -.
DR PhosphoSitePlus; Q8R4Y0; -.
DR MaxQB; Q8R4Y0; -.
DR PRIDE; Q8R4Y0; -.
DR ProteomicsDB; 272978; -. [Q8R4Y0-1]
DR ProteomicsDB; 272979; -. [Q8R4Y0-2]
DR ProteomicsDB; 272980; -. [Q8R4Y0-3]
DR ProteomicsDB; 272981; -. [Q8R4Y0-4]
DR ABCD; Q8R4Y0; 35 sequenced antibodies.
DR DNASU; 229499; -.
DR GeneID; 229499; -.
DR KEGG; mmu:229499; -.
DR CTD; 115350; -.
DR MGI; MGI:2442862; Fcrl1.
DR eggNOG; ENOG502S65W; Eukaryota.
DR InParanoid; Q8R4Y0; -.
DR OrthoDB; 53940at2759; -.
DR PhylomeDB; Q8R4Y0; -.
DR BioGRID-ORCS; 229499; 3 hits in 72 CRISPR screens.
DR ChiTaRS; Fcrla; mouse.
DR PRO; PR:Q8R4Y0; -.
DR Proteomes; UP000000589; Unplaced.
DR RNAct; Q8R4Y0; protein.
DR GO; GO:0009986; C:cell surface; ISO:MGI.
DR GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR GO; GO:0015026; F:coreceptor activity; ISO:MGI.
DR GO; GO:0004888; F:transmembrane signaling receptor activity; IBA:GO_Central.
DR GO; GO:0042113; P:B cell activation; ISO:MGI.
DR GO; GO:0007166; P:cell surface receptor signaling pathway; IBA:GO_Central.
DR Gene3D; 2.60.40.10; -; 2.
DR InterPro; IPR007110; Ig-like_dom.
DR InterPro; IPR036179; Ig-like_dom_sf.
DR InterPro; IPR013783; Ig-like_fold.
DR InterPro; IPR003599; Ig_sub.
DR Pfam; PF13895; Ig_2; 1.
DR SMART; SM00409; IG; 2.
DR SUPFAM; SSF48726; SSF48726; 2.
DR PROSITE; PS50835; IG_LIKE; 2.
PE 2: Evidence at transcript level;
KW Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein;
KW Immunoglobulin domain; Membrane; Phosphoprotein; Receptor;
KW Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT SIGNAL 1..16
FT /evidence="ECO:0000255"
FT CHAIN 17..343
FT /note="Fc receptor-like protein 1"
FT /id="PRO_0000331639"
FT TOPO_DOM 17..219
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 220..240
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 241..343
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT DOMAIN 17..109
FT /note="Ig-like C2-type 1"
FT DOMAIN 117..200
FT /note="Ig-like C2-type 2"
FT REGION 251..278
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT MOTIF 266..271
FT /note="ITIM motif 1"
FT MOTIF 279..284
FT /note="ITIM motif 2"
FT MOTIF 291..296
FT /note="ITIM motif 3"
FT MOTIF 325..330
FT /note="ITIM motif 4"
FT MOTIF 337..342
FT /note="ITIM motif 5"
FT COMPBIAS 254..273
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT CARBOHYD 51
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 202
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT DISULFID 138..185
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT VAR_SEQ 205..247
FT /note="Missing (in isoform 2)"
FT /evidence="ECO:0000303|PubMed:15302849,
FT ECO:0000303|PubMed:16141072"
FT /id="VSP_033296"
FT VAR_SEQ 206..208
FT /note="LSL -> KPT (in isoform 4)"
FT /evidence="ECO:0000303|Ref.3"
FT /id="VSP_033297"
FT VAR_SEQ 209..343
FT /note="Missing (in isoform 4)"
FT /evidence="ECO:0000303|Ref.3"
FT /id="VSP_033298"
FT VAR_SEQ 319..343
FT /note="SFQVSSGLYSKPRINIAHMDYEDAM -> VQGGIA (in isoform 3)"
FT /evidence="ECO:0000303|PubMed:15489334"
FT /id="VSP_033299"
FT CONFLICT 102
FT /note="A -> P (in Ref. 4; BAC30017)"
FT /evidence="ECO:0000305"
FT CONFLICT 232
FT /note="P -> L (in Ref. 4; BAC30017)"
FT /evidence="ECO:0000305"
FT CONFLICT 271
FT /note="S -> P (in Ref. 4; BAC30017)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 343 AA; 37277 MW; F4F235954A907B6C CRC64;
MLPWLLLLIC ALPCEPAGIS DVSLKTRPPG GWVMEGDKLV LICSVDRVTG NITYFWYRGA
LGFQLETKTQ PSLTAEFEIS DMKQSDADQY YCAANDGHDP IASELVSIHV RVPVSRPVLT
FGDSGTQAVL GDLVELHCKA LRGSPPIFYQ FYHESIILGN SSAPSGGGAS FNFSLTAEHS
GNFSCEASNG QGAQRSEVVA LNLTGLSLVP TENGISHLSL GLTGWLLGCL SPITMALIFC
YWLKRKIGRQ SEDPVRSPPQ TVLQGSTYPK SPDSRQPEPL YENVNVVSGN EVYSLVYHTP
QVLEPAAAQH VRTHGVSESF QVSSGLYSKP RINIAHMDYE DAM